About this Journal Submit a Manuscript Table of Contents
Parkinson’s Disease
Volume 2012 (2012), Article ID 614212, 8 pages
http://dx.doi.org/10.1155/2012/614212
Research Article

Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain

1Department of Neurology, Boston University School of Medicine, Boston, MA 02119, USA
2The Graduate Program in Bioinformatics, Boston University, Boston, MA 02215, USA
3Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA
4Whitehead Institute for Biomedical Research, Cambridge, MA, USA

Received 4 November 2011; Accepted 19 December 2011

Academic Editor: Kathleen A. Maguire-Zeiss

Copyright © 2012 Alexandra Dumitriu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Polymeropoulos, C. Lavedan, E. Leroy et al., “Mutation in the α-synuclein gene identified in families with Parkinson's disease,” Science, vol. 276, no. 5321, pp. 2045–2047, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Krüger, W. Kuhn, T. Müller et al., “Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease,” Nature Genetics, vol. 18, no. 2, pp. 106–108, 1998. View at Scopus
  3. J. J. Zarranz, J. Alegre, J. C. Gómez-Esteban et al., “The new mutation, E46K, of α-synuclein causes Parkinson and lewy body dementia,” Annals of Neurology, vol. 55, no. 2, pp. 164–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. Singleton, M. Farrer, J. Johnson et al., “α-synuclein locus triplication causes Parkinson's disease,” Science, vol. 302, no. 5646, p. 841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Chartier-Harlin, J. Kachergus, C. Roumier et al., “α-synuclein locus duplication as a cause of familial Parkinson's disease,” The Lancet, vol. 364, no. 9440, pp. 1167–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Ibáñez, A. M. Bonnet, B. Débarges et al., “Causal relation between α-synuclein gene duplication and familial Parkinson's disease,” The Lancet, vol. 364, no. 9440, pp. 1169–1171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Neystat, T. Lynch, S. Przedborski, N. Kholodilov, M. Rzhetskaya, and R. E. Burke, “α-synuclein expression in substantia nigra and cortex in Parkinson's disease,” Movement Disorders, vol. 14, no. 3, pp. 417–422, 1999.
  8. S. Kim, J.H. Seo, and Y.H. Suh, “Alpha-synuclein, Parkinson's disease, and Alzheimer's disease,” Parkinsonism & Related Disorders, vol. 10, supplement 1, pp. S9–S13, 2004.
  9. A. E. Kingsbury, S. E. Daniel, H. Sangha, S. Eisen, A. J. Lees, and O. J.F. Foster, “Alteration in α-synuclein mRNA expression in Parkinson's disease,” Movement Disorders, vol. 19, no. 2, pp. 162–170, 2004. View at Publisher · View at Google Scholar
  10. E. K. Tan, V. R. Chandran, S. Fook-Chong et al., “Alpha-synuclein mRNA expression in sporadic Parkinson's disease,” Movement Disorders, vol. 20, no. 5, pp. 620–623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Chiba-Falek, G. J. Lopez, and R. L. Nussbaum, “Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients,” Movement Disorders, vol. 21, no. 10, pp. 1703–1708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Westerlund, A. C. Belin, A. Anvret et al., “Cerebellar α-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material,” FASEB Journal, vol. 22, no. 10, pp. 3509–3514, 2008. View at Publisher · View at Google Scholar
  13. J. Fuchs, A. Tichopad, Y. Golub et al., “Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain,” FASEB Journal, vol. 22, no. 5, pp. 1327–1334, 2008. View at Publisher · View at Google Scholar
  14. K. Beyer, L. Ispierto, P. Latorre, E. Tolosa, and A. Ariza, “Alpha- and beta-synuclein expression in Parkinson disease with and without dementia,” Journal of the Neurological Sciences, vol. 310, no. 1-2, pp. 112–117, 2011. View at Publisher · View at Google Scholar
  15. M. Farrer, D. M. Maraganore, P. Lockhart et al., “α-synuclein gene haplotypes are associated with Parkinson's disease,” Human Molecular Genetics, vol. 10, no. 17, pp. 1847–1851, 2001. View at Scopus
  16. Y. Izumi, H. Morino, M. Oda et al., “Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan,” Neuroscience Letters, vol. 300, no. 2, pp. 125–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Holzmann, R. Krüger, A. M. M. Vieira Saecker et al., “Polymorphisms of the α-synuclein promoter: expression analyses and association studies in Parkinson's disease,” Journal of Neural Transmission, vol. 110, no. 1, pp. 67–76, 2003. View at Scopus
  18. J. C. Mueller, J. Fuchs, A. Hofer et al., “Multiple regions of α-synuclein are associated with Parkinson's disease,” Annals of Neurology, vol. 57, no. 4, pp. 535–541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Maraganore, M. De Andrade, A. Elbaz et al., “Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease,” Journal of the American Medical Association, vol. 296, no. 6, pp. 661–670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. H. Hadjigeorgiou, G. Xiromerisiou, V. Gourbali et al., “Association of α-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset,” Movement Disorders, vol. 21, no. 4, pp. 534–539, 2006. View at Publisher · View at Google Scholar
  21. I. Mizuta, W. Satake, Y. Nakabayashi et al., “Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease,” Human Molecular Genetics, vol. 15, no. 7, pp. 1151–1158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pals, S. Lincoln, J. Manning et al., “α-Synuclein promoter confers susceptibility to Parkinson's disease,” Annals of Neurology, vol. 56, no. 4, pp. 591–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Sotiriou, G. Gibney, A. D. Baxevanis, and R. L. Nussbaum, “A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease,” Neuroscience Letters, vol. 461, no. 2, pp. 196–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Linnertz, L. Saucier, D. Ge et al., “Genetic regulation of α-synuclein mRNA expression in various human brain tissues,” PLoS ONE, vol. 4, no. 10, Article ID e7480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. McCarthy, C. Linnertz, L. Saucier et al., “The effect of SNCA 3 region on the levels of SNCA-112 splicing variant,” Neurogenetics, vol. 12, no. 1, pp. 59–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Harrison, P. R. Heath, S. L. Eastwood, P. W. J. Burnet, B. McDonald, and R. C. A. Pearson, “The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins,” Neuroscience Letters, vol. 200, no. 3, pp. 151–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Jellinger, K. Seppi, G. K. Wenning, and W. Poewe, “Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease,” Journal of Neural Transmission, vol. 109, no. 3, pp. 329–339, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. T. G. Beach, C. H. Adler, L. F. Lue et al., “Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction,” Acta Neuropathologica, vol. 117, no. 6, pp. 613–634, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. L. B. Moran, D. C. Duke, M. Deprez, D. T. Dexter, R. K. B. Pearce, and M. B. Graeber, “Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease,” Neurogenetics, vol. 7, no. 1, pp. 1–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. L. B. Moran, L. Hickey, G. J. Michael et al., “Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies,” Acta Neuropathologica, vol. 115, no. 4, pp. 471–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Cantuti-Castelvetri, C. Keller-McGandy, B. Bouzou et al., “Effects of gender on nigral gene expression and parkinson disease,” Neurobiology of Disease, vol. 26, no. 3, pp. 606–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Pankratz, J. B. Wilk, J. C. Latourelle et al., “Genomewide association study for susceptibility genes contributing to familial Parkinson disease,” Human Genetics, vol. 124, no. 6, pp. 593–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. C. Latourelle, N. Pankratz, A. Dumitriu et al., “Genomewide association study for onset age in Parkinson disease,” BMC Medical Genetics, vol. 10, article 1471, p. 98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Spillantini, M. L. Schmidt, V. M. Y. Lee, J. Q. Trojanowski, R. Jakes, and M. Goedert, “α-synuclein in Lewy bodies,” Nature, vol. 388, no. 6645, pp. 839–840, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Preece and N. J. Cairns, “Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance,” Molecular Brain Research, vol. 118, no. 1-2, pp. 60–71, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. C. Birdsill, D. G. Walker, L. Lue, L. I. Sue, and T. G. Beach, “Postmortem interval effect on RNA and gene expression in human brain tissue,” Cell and Tissue Banking, vol. 12, no. 4, pp. 311–318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Dumitriu, C. D. Pacheco, J. B. Wilk et al., “Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study,” Human Molecular Genetics, vol. 20, no. 8, pp. 1478–1487, 2011. View at Publisher · View at Google Scholar